Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
about
Teaching bioinformatics and neuroinformatics by using free web-based toolsGenes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strainsDBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseasePrion protein in Alzheimer's pathogenesis: a hot and controversial issue.Prion protein and Abeta-related synaptic toxicity impairment.Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.Viral parkinsonism.The role of the anaphylatoxins in health and disease.Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's diseaseTranscriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier.Complement in the brain.C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.Practical considerations for choosing a mouse model of Alzheimer's disease.Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease.
P2860
Q24602046-4E6DDFE5-BD8E-4469-9D30-2F11382DC74CQ28559519-E4DB8451-D411-45D1-A308-07FC3141DD18Q30412535-861BCC89-262A-4757-B935-44FB0CF6749CQ33793485-5C895E78-63A8-4B85-880E-0F3B15F9787EQ34130611-8EA0EBBE-3763-47A0-93A9-DDF9713F3E2BQ34233877-65950F2C-9DE8-44BD-AE69-A4E6C580AC3EQ34550347-ADDC6352-520E-471E-95F9-9561FCF2C451Q34596492-43C94834-FEE6-4412-A6FB-1D58B55CE8B8Q34983578-86603219-4C79-46CB-BB84-3190B2E7A9EAQ35957099-E04C8FA0-820A-46CC-9C78-54327A2F85F7Q37599749-F7651FEB-8CDF-4750-B097-8D332B986DB8Q37872442-DA0A4B4D-EC81-4D12-A8A0-54E5835DC768Q42323104-75C1B9B5-94D9-4F60-A300-A0362AF628C4Q42407153-E632E735-5EC9-4595-ABEE-E0A175199414Q47135235-D2E5AF6D-7197-48C1-9406-0D5D543C5BD5Q53317230-BD9FB7AF-BFC1-4BD4-9893-984C2371A30F
P2860
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 April 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@en
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@nl
type
label
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@en
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@nl
prefLabel
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@en
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@nl
P2093
P2860
P1476
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
@en
P2093
Bruce T Lamb
Davis Ryman
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2007.02.017
P577
2007-04-02T00:00:00Z